Vaccines and the changing epidemiology of autism
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background The epidemiology of autism has been rather confusing, with very variable published prevalence figures and no clear incidence data. The cause of autism is unclear; vaccines have been incriminated. Methods Literature review and interpretation. Results The recorded prevalence of autism has increased considerably in recent years. This reflects greater recognition, with changes in diagnostic practice associated with more trained diagnosticians; broadening of diagnostic criteria to include a spectrum of disorder; a greater willingness by parents and educationalists to accept the label (in part because of entitlement to services); and better recording systems, among other factors. The cause(s) of autism remains unclear. There is a strong genetic component which, along with prenatally determined neuro‐anatomical/biochemical changes, makes any post‐natal ‘cause’ unlikely. Conclusions There has (probably) been no real increase in the incidence of autism. There is no scientific evidence that the measles, mumps and rubella (MMR) vaccine or the mercury preservative used in some vaccines plays any part in the aetiology or triggering of autism, even in a subgroup of children with the condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006 · cited 1×
“…of a paper with the unprepossessing title ‘Ileal-lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’ published in The Lancet in February 1998 (Wakefield et al 1998), which reported 12 children who had autistic spectrum disorder and bowel symptoms.”
BackgroundRetractedRetraction of an interpretation
Murch, S. H., Anthony, A., Casson, D. H., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15715-2 · Cited by 321
RetractedEpidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505
Pervasive Developmental Disorders in preschool children
Chakrabarti, S. (2001) · JAMA · doi:10.1001/jama.285.24.3093 · Cited by 1,132 · cited 1×
“Childhood autism prevalence for children born 1992 − 1995 was found to be 16.8 per 10 000 children; with total autistic spectrum disorder, 62.6 per 10 000 (Chakrabarti & Fombonne 2001).”
BackgroundInfluentialThe epidemiology of autism: a review
FOMBONNE, E. (1999) · Psychological Medicine · doi:10.1017/s0033291799008508 · Cited by 981 · cited 1×
“Early epidemiological studies suggested a prevalence of 4–10 affected individuals per 10 000 children; recent population-based surveys, however, have shown a much higher prevalence, 40–60 cases per 10 000 children (Fombonne 1998, 2003).”
BackgroundAutism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association
Taylor, B., Miller, E., Farrington, C., Petropoulos, M.-C., Favot-Mayaud, I., Li, J., & Waight, P. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01239-8 · Cited by 753
Self-citationTime trends in autism and in MMR immunization coverage in California
Dales, L. (2001) · JAMA · doi:10.1001/jama.285.9.1183 · Cited by 340
No evidence for a new variant of measles-mumps-rubella-induced autism
Fombonne, E., & Chakrabarti, S. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.e58 · Cited by 312 · cited 1×
“There was no associated increase in bowel problems or regression among children with autism (Fombonne & Chakrabarti 2001; Taylor et al .”
BackgroundMMR vaccination and pervasive developmental disorders: a case-control study
Smeeth, L., Cook, C., Fombonne, E., Heavey, L., Rodrigues, L. C., Smith, P. G., & Hall, A. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17020-7 · Cited by 263
Parker, S. K., Schwartz, B., Todd, J., & Pickering, L. K. (2004) · Pediatrics · doi:10.1542/peds.2004-0434 · Cited by 242
Cited by
Bakioğlu, F., Korkmaz, O., & Ercan, H. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00331-y · Cited by 812
Autism spectrum disorders-a genetics review
Miles, J. H. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181ff67ba · Cited by 567
The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Baggs, J., Gee, J., Lewis, E., Fowler, G., Benson, P., Lieu, T., Naleway, A., Klein, N. P., Baxter, R., Belongia, E., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-1722h · Cited by 349
Taylor, B., Jick, H., & MacLaughlin, D. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003219 · Cited by 176
Self-citationAutism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72
Metadata
- Authors
- Taylor, B.
- Venue
- Child: Care, Health and Development
- Publisher
- Wiley
- Published
- 2006-08-09
- Volume
- 32
- Issue
- 5
- Pages
- 511-519
- ISSN
- 0305-1862 (ISSN-L)
- 1365-2214
- OpenAlex
- W1994489056
- Cited by
- 73
- References
- 11
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaccines and the changing epidemiology of autism. https://app.cochat.ai/papers/10.1111/j.1365-2214.2006.00655.x
- The paper
- Taylor, B. (2006). Vaccines and the changing epidemiology of autism. Child: Care, Health and Development. https://doi.org/10.1111/j.1365-2214.2006.00655.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.